Autoimmune Disease Treatment Market Report 2023 Global Growth, Top Pharmaceutical Companies, Research and Development, Expansion, Mergers and Acquisitions

Market Highlights:

An autoimmune disease is a condition in which body's immune system destroys its own body tissue. There are more than 80 different type of autoimmune disorders but the most common are multiple sclerosis, IBD, diabetes, rheumatoid arthritis, psoriasis, and others. Autoimmune disease may result in abnormal growth of an organ, the destruction of body tissue, and changes in organ function

According to the National Institutes of Health (NIH), around 23.5 million Americans are suffering from autoimmune disease. NIH has also estimated that the annual direct health care costs for autoimmune disease are near to the USD 100 billion. Whereas for cancers, and heart & strokes, the cost is around USD 57 billion, and USD 200 billion respectively.
Notably, growing public awareness, and the increasing prevalence of autoimmune diseases, and other related complications are the key factors driving the autoimmune disease treatment market. Government and other different private associations have started educating people about diseases through seminars, and conferences. For instance, the American Autoimmune Related Diseases Association in collaboration with the National Coalition of Autoimmune Patient Groups conducts a program, named Autoimmune Research Network (ARNet). Through this research network, researchers empowers patients by supporting their participation in research on autoimmune diseases by gathering patient information. This information is majorly helpful during clinical trials.

Various other factors such as technological advancements, unmet medical needs, increasing government assistance, rising prevalence of co-existing disorders, improving regulatory framework, improving funding and reimbursement policies, and increasing adoption rate, are continuously contributing towards the growth of the global autoimmune disease treatment market.

Despite these drivers, there are some issues associated with autoimmune disease treatment market. High cost of treatment, presence of misbranded drugs, side-effects of treatment, and poor healthcare system in low or middle-income countries, may hamper the growth of the market. It is estimated that the autoimmune disease treatment market is expected to grow at a CAGR 11.2% during the forecast period of 2017-2023.

Get an Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/5586

Regional Analysis:

Geographically, the global autoimmune disease treatment market is segmented into four major regions such as Americas, Europe, Asia Pacific and the Middle East and Africa. The Americas is projecting dominance on the global autoimmune disease treatment market owing to the high prevalence of autoimmune diseases and well-developed healthcare infrastructure in this region.
The Europe region is projected to account for the second largest share in the global autoimmune disease treatment market owing to the increasing investment in the healthcare sector and rise in healthcare expenditure by the population in this region. The Asia Pacific region is projecting fastest growth in the global autoimmune disease treatment market owing to the high population and increasing pool of individuals suffering from autoimmune diseases in this region.
The Middle East and Africa region is projecting slow growth in the global autoimmune disease treatment market owing to the poor healthcare infrastructure and lack of awareness in the underdeveloped areas of this region.

Key players of Global Autoimmune Disease Treatment Market:

The pharmaceutical companies are focusing on increasing their research and development expenditure in order to introduce highly effective and innovative medications in the market which in turn is fueling the competition in the global autoimmune disease treatment market. The strategic mergers and acquisitions among the players are aiding the expansion of their businesses in the global autoimmune disease treatment market.

• Abbott Laboratories,
• Amgen Inc.
• Genentech Inc.
• Bayer Schering Pharma AG
• Biogen Idec Inc.
• Bio-Rad
• Chugai Pharmaceutical Co. Ltd.
• Danaher
• Elan Corporation Plc
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• GlaxoSmithKline Plc
• HYCOR Biomedical
• Johnson & Johnson Inc.
• Merck & Co. Inc.
• Siemens
• Squibb Company
• Thermo Fisher Scientific, and others.

Pharma News:

On 25th July 2018, Corbus Pharmaceuticals, a clinical stage drug development company, has announced the commencement of the phase 3 study of Lenabasum for the treatment of dermatomyositis, a rare autoimmune disease.

Avail Amazing Discount on Report @ https://www.marketresearchfuture.com/check-discount/5586

Segments:
The global autoimmune disease treatment market has been segmented on the basis of disease type, diagnosis, therapeutic products and distribution channel.
Based on disease types, the autoimmune disease treatment market is segmented into localized and systematic. The localized segment is sub-segmented into multiple sclerosis, inflammatory bowel disease, diabetes, and others. The systematic disease type segment is sub-segmented into rheumatoid arthritis, psoriasis, lupus, and others.
Based on diagnosis, the autoimmune disease treatment market is segmented into ELISA, dot blot, line blot, agglutination, double immune diffusion, western blotting, multiplex immunoassay, and others. Based on therapeutic products, the autoimmune disease treatment market is segmented into drugs, and therapeutic and monitoring equipment. The drugs segment includes biologics, immunosuppressant, anti-inflammatory drugs, corticosteroids, and non-steroidal anti-inflammatory drugs. Based on distribution channel, the autoimmune disease treatment market is segmented into hospitals & clinics, diagnostic centers, drug stores, pharmacies, and others.

BRIEF TOC:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment

…TOC CONTINUED

Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5586

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.